478912-71-9

Upstream product

• 1513-65-1 2,6-difluoro pyridine 
• 2393-23-9 4-methoxy-benzylamine 

Downstream Products

• 1196662-21-1 (5-bromo-6-fluoropyridin-2-yl)(4-methoxybenzyl)amine 
• 1303426-58-5 {6-fluoro-5-[hydroxy-(5-methyl-1-triisopropylsilanyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]pyridin-2-yl}-(4-methoxybenzyl)carbamic acid tert-butyl ester 
• 1196662-25-5 (6-fluoro-5-formylpyridin-2-yl)(4-methoxybenzyl)carbamic acid tert-butyl ester 
• 1196662-24-4 2-fluoro-6-(4-methoxybenzylamino)pyridine-3-carbaldehyde 
• 1196662-23-3 [2-fluoro-6-(4-methoxybenzylamino)pyridin-3-yl]methanol 
• 1196662-22-2 2-fluoro-6-(4-methoxybenzylamino)nicotinic acid methyl ester 

Relevant academic research and scientific papers

HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS

This invention is directed to heteroaryl-substituted sulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.

Compounds and methods for kinase modulation, and indications therefor

Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereo

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereo

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereo

Novel N-formyl hydroxylamine compounds, compositions and methods of use

N-[1-oxo-2-alkyl-3-(N-hydroxyformamido)-propyl]-(carbonylamino-aryl or -heteroaryl)-azacyclo4-7alkanes or thiazacyclo4-7alkanes or imidazacyclo4-7alkanes have interesting properties, e.g., in the treatment or prevention of disorders amenable to treatment by peptidyl deformylase inhibitors such as treatment of bacterial infections.